Acadia Healthcare (ACHC)
(Delayed Data from NSDQ)
$42.08 USD
-0.41 (-0.96%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $42.06 -0.02 (-0.05%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$42.08 USD
-0.41 (-0.96%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $42.06 -0.02 (-0.05%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth C Momentum D VGM
Zacks News
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Humana (HUM) Boosts Healthcare Choices for MA Members in Denver
by Zacks Equity Research
Humana (HUM) enters into a deal with Denver Health to expand its local provider network across the Denver area as well as offer greater care access to its Medicare Advantage members of the region.
4 Undervalued Medical Stocks to Buy Amid High Market Volatility
by Indrajit Bandyopadhyay
Amid volatility, undervalued companies with solid prospects cushion investors from market jitters, while their robust fundamentals ensure higher returns. ACHC, PGNY, EGRX and NRBO are four such stocks.
All You Need to Know About Acadia Healthcare (ACHC) Rating Upgrade to Buy
by Zacks Equity Research
Acadia Healthcare (ACHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Down -11.71% in 4 Weeks, Here's Why You Should You Buy the Dip in Acadia Healthcare (ACHC)
by Zacks Equity Research
Acadia Healthcare (ACHC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Here's Why Investors Should Retain Acadia Healthcare (ACHC)
by Zacks Equity Research
Acadia Healthcare (ACHC) is well-poised for growth on the solid demand for behavioral healthcare services, the continuous pursuit of expansion initiatives and growing cash reserves.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems are part of the Zacks Industry Outlook article.
Implied Volatility Surging for Acadia Healthcare (ACHC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
5 Hospital Stocks to Watch Amid Improving Industry Trends
by Kaibalya Pravo Dey
Cost optimization efforts and rising patient volumes for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving occupancy rates.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Acadia Healthcare (ACHC) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Acadia Healthcare (ACHC) Up 11% in 3 Months: More Room to Run?
by Zacks Equity Research
Acadia Healthcare (ACHC) is well-poised for growth on an expansive healthcare portfolio, which in turn, boosts its patient volumes.
Community Health (CYH) Q2 Earnings Top on Rising Admissions
by Zacks Equity Research
Community Health (CYH) expects net operating revenues in the range of $12,200 million-$12,600 million for 2023.
Pediatrix (MD) Q2 Earnings Meet Estimates, Revenues Up Y/Y
by Zacks Equity Research
Pediatrix (MD) reiterates adjusted EBITDA guidance in the range of $235-$245 million for 2023 compared with $241 million in 2022.
Humana (HUM) Q2 Earnings Beat on Strong Individual MA Unit
by Zacks Equity Research
Humana's (HUM) Q2 results gain from strong pharmacy revenues and revenue growth within the Insurance segment, partly offset by higher benefits expenses.
Acadia Healthcare (ACHC) Q2 Earnings Beat on Higher Admissions
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q2 results indicate improved patient days and revenue per patient day. Management expects 2023 adjusted EPS of $3.25-$3.50.
Acadia Healthcare (ACHC) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 10.84% and 3.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Will US Business Strength Aid Acadia's (ACHC) Q2 Earnings?
by Zacks Equity Research
Strength in US operations, stemming from higher patient days and revenue per patient day, is expected to have aided Acadia Healthcare's (ACHC) Q2 performance. Rising expenses are likely to have partially offset the same.
Here's What to Expect From Acadia Healthcare's (ACHC) Q2 Earnings
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q2 results are likely to reflect increased patient volumes across its U.S. operations, partly offset by a higher expense base.
Acadia Healthcare's (ACHC) New Facility Boosts Pennsylvania Reach
by Zacks Equity Research
Acadia Healthcare (ACHC) commences operations at one of the two hospitals, which form a part of its JV with Geisinger. The company is committed to offer enhanced behavioral health services in Pennsylvania.
Acadia Healthcare (ACHC) Inks JV to Better Serve New Hampshire
by Zacks Equity Research
Acadia Healthcare (ACHC) enters into a JV with New Hampshire-based SolutionHealth to build a behavioral health facility and address the dire need for advanced behavioral health services across the state.
Acadia Healthcare (ACHC) Expands With New Hospital in Michigan
by Zacks Equity Research
Acadia Healthcare's (ACHC) partnership with Bronson Healthcare to expand its footprint in Michigan with Bronson Behavioral Health Hospital.
Should You Retain Acadia Healthcare (ACHC) in Your Portfolio?
by Zacks Equity Research
Acadia Healthcare's (ACHC) top line is likely to receive support from growth in specialty treatment and acute inpatient psychiatric facilities.
Acadia Healthcare (ACHC) Down 6.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.